Active substance | Pritelivir |
Holder | myTomorrows |
Status | Rnning |
Indication | treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient |
Public documents | |
Last update | 01/12/2022 |
Active substance | Pritelivir |
Holder | myTomorrows |
Status | Rnning |
Indication | treatment of acyclovir-resistant mucocutaneous HSV (Herpes Simplex Virus) infections in immunocompromised patient |
Public documents | |
Last update | 01/12/2022 |